tiprankstipranks
Trending News
More News >
Arcus Biosciences reports Q1 EPS ($1.14), consensus ($1.01)
PremiumThe FlyArcus Biosciences reports Q1 EPS ($1.14), consensus ($1.01)
1d ago
RCUS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RCUS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4d ago
Arcus Biosciences price target lowered to $14 from $29 at Barclays
Premium
The Fly
Arcus Biosciences price target lowered to $14 from $29 at Barclays
15d ago
RCUS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsRCUS Upcoming Earnings Report: What to Expect?
2M ago
Arcus Biosciences price target lowered to $17 from $22 at BofA
Premium
The Fly
Arcus Biosciences price target lowered to $17 from $22 at BofA
3M ago
Arcus Biosciences falls -14.8%
Premium
The Fly
Arcus Biosciences falls -14.8%
3M ago
Arcus Biosciences retains rights to casdatifan
PremiumThe FlyArcus Biosciences retains rights to casdatifan
3M ago
Arcus Biosciences prices 13.6M shares at $11.00 in underwritten offering
Premium
The Fly
Arcus Biosciences prices 13.6M shares at $11.00 in underwritten offering
3M ago
Arcus Biosciences’ Casdatifan: Promising Efficacy and Safety Profile Highlights Buy Rating
Premium
Ratings
Arcus Biosciences’ Casdatifan: Promising Efficacy and Safety Profile Highlights Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100